PUNE, India, December 22, 2015 /PRNewswire/ --
ReportsnReports.com adds "Muscular Dystrophy Global Clinical Trials Review, H2, 2015" market research report that provides an overview of muscular dystrophy clinical trials scenario, enhances decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
This report provides top line data relating to the clinical trials on Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. Complete report on Muscular Dystrophy Clinical Trials spread across 79 pages, supported with 23 tables and 24 figures is now available at http://www.reportsnreports.com/reports/445331-muscular-dystrophy-global-clinical-trials-review-h2-2015.html .
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report provides a snapshot of the global clinical trials landscape with top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status and reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company. The report also provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment, enrollment trends for the past five years and latest news for the past three months.
Order a copy of Muscular Dystrophy Global Clinical Trials Review, H2, 2015 market research report at http://www.reportsnreports.com/purchase.aspx?name=445331 .
Reasons to buy
Another newly published market research report titled on EpiCast Report: Duchenne Muscular Dystrophy - Epidemiology Forecast to 2023 provides an overview of the risk factors, comorbidities, and the global and historical trends for DMD in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of DMD and Becker Muscular Dystrophy (BMD) in men, segmented by age (in 10-year age groups beginning at 0 years and ending at =40 years for cases of DMD with a special focus on the subgroup of ages 5-13 years, and in 15-year age groups beginning at 0 years and ending at =75 years for cases of BMD) in these markets. Additionally, the diagnosed prevalent cases of DMD (all ages) are further segmented by the applicability of exon skipping therapies (exons 51, 45, 53, and 44) and nonsense mutations. Duchenne Muscular Dystrophy market research report of 51 pages is available at http://www.rnrmarketresearch.com/epicast-report-duchenne-muscular-dystrophy-epidemiology-forecast-to-2023-market-report.html .
Explore more reports on Pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
Copyright©2015 PR Newswire.
All rights reserved